Amylyx Pharmaceuticals announced Thursday that it has begun the process of voluntarily withdrawing its ALS drug, Relyvrio, from the market after it failed to prove efficacy in a large clinical trial.…
Read More
ALS drug Relyvrio withdrawn from market after failed clinical trial
